Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for treating patients at risk for costimulation blockade resistant rejection with belatacept

Methods for treating patients at risk for costimulation blockade resistant rejection with belatacept

US Patent 10488413 · Granted Nov 26, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Gene signatures for monitoring acute rejection and methods of using same2024
Methods for treating costimulation blockade resistant rejection2022
Methods for treating costimulation blockade resistant rejection2022
Methods for treating costimulation blockade resistant rejection2022
Methods for determination of calcineurin activity and uses in predicting therape2013
Anti-CD86 antibody2013
CD86 and CD80 receptor competition assays2009
Calcium receptor modulating agents2007
Methods of treating inflammatory and immune diseases using inhibitors of IκB kin2005
Peptide mimics of the cytokine receptor common &ggr; chain and methods and compo2002